This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Regents of the University of Minnesota, Boston Scientific Scimed, Inc.. Active years: 2022-2024.
Company Filing History:
2 out of 2,369 
1 out of 6,594 
Years Active: 2022-2024
Title: Samuel Hanson: Innovator in Tumor Treatment and Disease Management
Introduction
Samuel Hanson is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical treatments, particularly in the area of tumor therapy and disease management. With a total of 2 patents, his work reflects a commitment to advancing healthcare solutions.
Latest Patents
Hanson's latest patents include innovative methods for treating tissue volumes. One of his patents focuses on a combination tumor treatment that involves administering an implantable composition with a releasable membrane-active agent. This method allows for localized release of the agent to the target site, followed by treatment using a pulsed electric field. Another patent discloses compositions and methods for treating diseases, particularly cancer, using a combination of membranolytic polymers and chemotherapeutic agents.
Career Highlights
Throughout his career, Samuel Hanson has worked with esteemed organizations such as the Regents of the University of Minnesota and Boston Scientific Scimed, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical technology.
Collaborations
Hanson has collaborated with notable colleagues, including Chun Wang and Bruce R Forsyth. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the medical field.
Conclusion
Samuel Hanson is a distinguished inventor whose work in tumor treatment and disease management showcases his dedication to improving healthcare. His innovative patents and collaborations highlight his significant contributions to medical science.